GlassScriptPhysician profile
Michael B Purnell
NPI 1982652459
$126,450.06
in general payments reported to CMS, 2019-2025
21 companies · $55K in 2025
The $55K reported for 2025 was more than what 95% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,706 · 2020: $1,039 · 2021: $16K · 2022: $6,291 · 2023: $15K · 2024: $30K · 2025: $55K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $90K · Travel and Lodging: $4,890 · Charitable Contribution: $2,888 · Food and Beverage: $1,499 · Gift: $58.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $90,314.83 |
| Travel and Lodging | $4,890.07 |
| Charitable Contribution | $2,888.43 |
| Food and Beverage | $1,498.84 |
| Gift | $58.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shoulder Innovations, INC. | $99,670.24 | 2019-2025 | Inset System |
| Genesis Software Innovations, LLC | $19,053.92 | 2021-2025 | |
| Arthrex, INC. | $3,439.91 | 2019-2022 | |
| Sequoia Surgical, INC. | $2,177.73 | 2019-2021 | |
| Cornerstone Medical Associates, INC. | $893.73 | 2022-2025 | |
| Orthofix Medical, INC. | $238.34 | 2019 | |
| Amgen INC. | $144.17 | 2021-2024 | Evenity |
| Wright Medical Technology, INC. | $135.00 | 2019 | |
| Medical Device Business Services, INC. | $126.77 | 2019-2024 | Velys |
| Depuy Synthes Sales INC. | $113.57 | 2022 | |
| Orthalign INC | $100.00 | 2019 | |
| Smith+Nephew, INC. | $95.00 | 2024 | Evos |
| Zimmer Biomet Holdings, INC. | $89.36 | 2023 | Persona |
| Radius Health, INC. | $60.47 | 2021-2022 | |
| Davol INC. | $36.60 | 2025 | Arista |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $24.33 | 2025 | Champion |
| Heron Therapeutics, INC. | $23.01 | 2023 | Zynrelef |
| Nevro Corp. | $15.37 | 2022 | |
| Kci USA, INC. | $12.54 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$691,145.06 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Purnell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.